Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - CN
$ 0.1407
-13.2 %
$ 3.33 M
Market Cap
-0.03
P/E
BALANCE SHEET
53.3 M
ASSETS
13.8 M
LIABILITIES
39.5 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Universe Pharmaceuticals INC
| Current Assets | 36.8 M |
| Cash & Short-Term Investments | 18.5 M |
| Receivables | 10.7 M |
| Other Current Assets | 7.58 M |
| Non-Current Assets | 16.5 M |
| Long-Term Investments | 685 K |
| PP&E | 15 M |
| Other Non-Current Assets | 806 K |
| Current Liabilities | 13.8 M |
| Accounts Payable | 4.59 M |
| Short-Term Debt | 5.48 M |
| Other Current Liabilities | 3.69 M |
| Non-Current Liabilities | 0 |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Sep-2023 | Sep-2022 | Sep-2021 | Sep-2020 | Sep-2019 | Sep-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 5.3 | 5.7 | 8.1 | 10.1 | 3.2 | 6.2 |
| Short Term Investments | 13.2 | 13.1 | 13.7 | 0 | 0 | 0 |
| Receivables | 10.7 | 15.2 | 15.8 | 10.9 | 6.4 | 7.6 |
| Inventory | 3.3 | 2.2 | 2.5 | 1.9 | 2.6 | 8.1 |
| Other Current Assets | 4.2 | 5.3 | 10.4 | 0 | 16.3 K | 8.48 K |
| Total Current Assets | 36.8 | 41.5 | 50.5 | 23.3 | 12.2 | 22.0 |
| PP&E | 15.0 | 13.6 | 15.4 | 4.4 | 4.6 | 5.1 |
| Intangible Assets | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 |
| Other Long Term Assets | 0 | 2.2 | 2.5 | 0 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 53.3 | 59.5 | 70.1 | 28.8 | 17.8 | 28.1 |
| LIABILITIES | ||||||
| Accounts Payable | 4.6 | 3.1 | 5.3 | 2.7 | 1.9 | 2.9 |
| Short Term Debt | 5.5 | 3.9 | 4.3 | 2.6 | 2.5 | 2.6 |
| Other Current Liabilities | 3.3 | 5.9 | 0.5 | 1.3 | 0.4 | 11.9 |
| Total Current Liabilities | 13.8 | 13.1 | 11.2 | 8.0 | 5.5 | 18.4 |
| Long Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 13.8 | 13.1 | 11.2 | 8.0 | 5.5 | 18.4 |
| EQUITY | ||||||
| Common Stock | 68 K | 68 K | 68 K | 50 K | 50 K | 50 K |
| Retained Earnings | 10.2 | 16.3 | 25.1 | 13.7 | 6.2 | 2.8 |
| Other Accumulative Comprehensive Income/Loss | 26.3 K | 0.8 | 4.5 | 3.3 | 2.5 | 3.1 |
| Total Equity | 39.5 | 46.4 | 58.9 | 20.8 | 12.4 | 9.7 |
| Total Liabilities and Equity | 53.3 | 59.5 | 70.1 | 28.8 | 17.8 | 28.1 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 3.6 | 3.6 | 3.6 | 3.7 | 3.7 | 21.0 |